{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T07:06:48Z","timestamp":1692688008162},"reference-count":57,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0104","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T22:09:02Z","timestamp":1500588542000},"page":"131-140","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Mitral Valve Surgery in Patients With Dilated Cardiomyopathy and Severe Functional Mitral Regurgitation"],"prefix":"10.1253","volume":"82","author":[{"given":"Hyemoon","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center"},{"name":"Division of Cardiology, Department of Internal Medicine, Kyung Hee University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Amaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takahama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Asakura","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center"},{"name":"Department of Cardiovascular Medicine, Hyogo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics: 2014 update report from the American Heart Association. <i>Circulation<\/i> 2014; 129: e28\u2013e292."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2016; 67: 2996\u20133010.","DOI":"10.1016\/j.jacc.2016.03.590"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. <i>Am Heart J<\/i> 2002; 144: 524\u2013529.","DOI":"10.1067\/mhj.2002.123575"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Carpentier A. Cardiac valve surgery: The \u201cFrench correction\u201d. <i>J Thorac Cardiovasc Surg<\/i> 1983; 86: 323\u2013337.","DOI":"10.1016\/S0022-5223(19)39144-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. <i>Heart<\/i> 2011; 97: 1675\u20131680.","DOI":"10.1136\/hrt.2011.225789"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. <i>Circulation<\/i> 2000; 102: 1400\u20131406.","DOI":"10.1161\/01.CIR.102.12.1400"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kaneko H, Suzuki S, Uejima T, Kano H, Matsuno S, Otsuka T, et al. Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure. <i>Heart Vessels<\/i> 2014; 29: 801\u2013807.","DOI":"10.1007\/s00380-013-0448-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wada Y, Ohara T, Funada A, Hasegawa T, Sugano Y, Kanzaki H, et al. Prognostic impact of functional mitral regurgitation in patients admitted with acute decompensated heart failure. <i>Circ J<\/i> 2016; 80: 139\u2013147.","DOI":"10.1253\/circj.CJ-15-0663"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bristow MR, O\u2019Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, et al. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy: Bucindolol Investigators. <i>Circulation<\/i> 1994; 89: 1632\u20131642.","DOI":"10.1161\/01.CIR.89.4.1632"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. <i>N Engl J Med<\/i> 2002; 346: 1357\u20131365.","DOI":"10.1056\/NEJMoa012630"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. <i>Circulation<\/i> 2004; 110(Suppl 1): II103\u2013II108.","DOI":"10.1161\/01.CIR.0000138196.06772.4e"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. <i>Eur J Cardiothorac Surg<\/i> 2005; 27: 847\u2013853.","DOI":"10.1016\/j.ejcts.2004.12.031"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. De Bonis M, Taramasso M, Verzini A, Ferrara D, Lapenna E, Calabrese MC, et al. Long-term results of mitral repair for functional mitral regurgitation in idiopathic dilated cardiomyopathy. <i>Eur J Cardiothorac Surg<\/i> 2012; 42: 640\u2013646.","DOI":"10.1093\/ejcts\/ezs078"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. <i>J Am Coll Cardiol<\/i> 2005; 45: 381\u2013387.","DOI":"10.1016\/j.jacc.2004.09.073"},{"key":"15","unstructured":"15. Ethical guidelines for medical and health research involving human subjects. http:\/\/www.mhlw.go.jp\/file\/06-seisakujouhou-10600000-Daijinkanboukouseikagakuka\/0000080278.pdf (assessed March 31, 2015)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. <i>J Am Soc Echocardiogr<\/i> 2005; 18: 1440\u20131463.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lang RM, Borow KM, Neumann A, Janzen D. Systemic vascular resistance: An unreliable index of left ventricular afterload. <i>Circulation<\/i> 1986; 74: 1114\u20131123.","DOI":"10.1161\/01.CIR.74.5.1114"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2014; 63: e57\u2013e185.","DOI":"10.1161\/CIR.0000000000000031"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). <i>Eur J Echocardiogr<\/i> 2010; 11: 307\u2013332.","DOI":"10.1093\/ejechocard\/jeq031"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. <i>Eur J Cardiothorac Surg<\/i> 2012; 41: 734\u2013744.","DOI":"10.1093\/ejcts\/ezs043"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. O\u2019Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2 \u2013 isolated valve surgery. <i>Ann Thorac Surg<\/i> 2009; 88(Suppl): S23\u2013S42.","DOI":"10.1016\/j.athoracsur.2009.05.056"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II) survey on hospitalized acute heart failure patients: Description of population. <i>Eur Heart J<\/i> 2006; 27: 2725\u20132736.","DOI":"10.1093\/eurheartj\/ehl193"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Agricola E, Ielasi A, Oppizzi M, Faggiano P, Ferri L, Calabrese A, et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. <i>Eur J Heart Fail<\/i> 2009; 11: 581\u2013587.","DOI":"10.1093\/eurjhf\/hfp051"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Agricola E, Stella S, Figini F, Piraino D, Oppizzi M, D\u2019Amato R, et al. Non-ischemic dilated cardiopathy: Prognostic value of functional mitral regurgitation. <i>Int J Cardiol<\/i> 2011; 146: 426\u2013428.","DOI":"10.1016\/j.ijcard.2010.10.096"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Stolfo D, Merlo M, Pinamonti B, Poli S, Gigli M, Barbati G, et al. Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. <i>Am J Cardiol<\/i> 2015; 115: 1137\u20131143.","DOI":"10.1016\/j.amjcard.2015.01.549"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dell\u2019Italia LJ, Meng QC, Balcells E, Straeter-Knowlen IM, Hankes GH, Dillon R, et al. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. <i>Am J Physiol<\/i> 1995; 269: H2065\u2013H2073.","DOI":"10.1152\/ajpheart.1995.269.6.H2065"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, Griffin BP. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. <i>J Am Coll Cardiol<\/i> 2000; 36: 208\u2013212.","DOI":"10.1016\/S0735-1097(00)00721-X"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Talwar S, Squire IB, Davies JE, Ng LL. The effect of valvular regurgitation on plasma cardiotrophin-1 in patients with normal left ventricular systolic function. <i>Eur J Heart Fail<\/i> 2000; 2: 387\u2013391.","DOI":"10.1016\/S1388-9842(00)00105-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Carabello BA. The current therapy for mitral regurgitation. <i>J Am Coll Cardiol<\/i> 2008; 52: 319\u2013326.","DOI":"10.1016\/j.jacc.2008.02.084"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. <i>J Am Coll Cardiol<\/i> 2003; 41: 765\u2013770.","DOI":"10.1016\/S0735-1097(02)02937-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J 3rd. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: Insights from mechanical activation strain mapping. <i>J Am Coll Cardiol<\/i> 2004; 44: 1619\u20131625.","DOI":"10.1016\/j.jacc.2004.07.036"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, et al. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. <i>Eur J Echocardiogr<\/i> 2006; 7: 31\u201339.","DOI":"10.1016\/j.euje.2005.03.008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. <i>N Engl J Med<\/i> 2002; 346: 1845\u20131853.","DOI":"10.1056\/NEJMoa013168"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. <i>Europace<\/i> 2011; 13: 829\u2013838.","DOI":"10.1093\/europace\/eur047"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, et al. ACCF\/HRS\/AHA\/ASE\/HFSA\/SCAI\/SCCT\/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. <i>J Am Coll Cardiol<\/i> 2013; 61: 1318\u20131368.","DOI":"10.1016\/j.jacc.2012.12.017"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Associationof the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). <i>Eur Heart J<\/i> 2008; 29: 2388\u20132442.","DOI":"10.1093\/eurheartj\/ehn309"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Di Salvo TG, Acker MA, Dec GW, Byrne JG. Mitral valve surgery in advanced heart failure. <i>J Am Coll Cardiol<\/i> 2010; 55: 271\u2013282.","DOI":"10.1016\/j.jacc.2009.08.059"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Giannini C, Fiorelli F, De Carlo M, Guarracino F, Faggioni M, Giordano P, et al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. <i>Am J Cardiol<\/i> 2016; 117: 271\u2013277.","DOI":"10.1016\/j.amjcard.2015.10.044"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. De Bonis M, Bolling SF. Mitral valve surgery: Wait and see vs. early operation. <i>Eur Heart J<\/i> 2013; 34: 13a\u201319a.","DOI":"10.1093\/eurheartj\/ehs248"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Trichon BH, Glower DD, Shaw LK, Cabell CH, Anstrom KJ, Felker GM, et al. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. <i>Circulation<\/i> 2003; 108(Suppl 1): II103\u2013II110.","DOI":"10.1161\/01.cir.0000087656.10829.df"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Acker MA, Jessup M, Bolling SF, Oh J, Starling RC, Mann DL, et al. Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial. <i>J Thorac Cardiovasc Surg<\/i> 2011; 142: 569\u2013574, 574.e1.","DOI":"10.1016\/j.jtcvs.2010.10.051"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>Circulation<\/i> 2014; 129: e521\u2013e643.","DOI":"10.1161\/CIR.0000000000000031"},{"key":"43","unstructured":"43. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS); Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Bar\u00f3n-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). <i>Eur Heart J<\/i> 2012; 33: 2451\u20132496."},{"key":"44","unstructured":"44. Japanese Circulation Society. Guidelines for surgical and interventional treatment of valvular haert [sic] disease (JCS 2012) (in Japanese). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2012_ookita_h.pdf (accessed June 2017)."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Yin L, Wang Z, Shen H, Min J, Ling X, Xi W. Coronary artery bypass grafting versus combined coronary artery bypass grafting and mitral valve repair in treating ischaemic mitral regurgitation meta-analysis. <i>Heart Lung Circ<\/i> 2014; 23: 905\u2013912.","DOI":"10.1016\/j.hlc.2014.03.031"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. <i>N Engl J Med<\/i> 2016; 374: 1932\u20131941.","DOI":"10.1056\/NEJMoa1602003"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. <i>N Engl J Med<\/i> 2014; 370: 23\u201332.","DOI":"10.1056\/NEJMoa1312808"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Takeda K, Taniguchi K, Shudo Y, Kainuma S, Hamada S, Matsue H, et al. Mechanism of beneficial effects of restrictive mitral annuloplasty in patients with dilated cardiomyopathy and functional mitral regurgitation. <i>Circulation<\/i> 2010; 122(Suppl 1): S3\u2013S9.","DOI":"10.1161\/CIRCULATIONAHA.109.927855"},{"key":"49","unstructured":"49. Murakami M, Yamaguchi H, Suda Y, Asai T, Sueishi M, Matsumura T. Mitral valve repair for 52 patients with severe left ventricular dysfunction. <i>Ann Thorac Cardiovasc Surg<\/i> 2009; 15: 160\u2013164."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Santana O, Lamelas J. Surgical options of ischemic mitral regurgitation. <i>Cardiol Rev<\/i> 2010; 18: 163\u2013170.","DOI":"10.1097\/CRD.0b013e3181d35613"},{"key":"51","unstructured":"51. Madesis A, Tsakiridis K, Zarogoulidis P, Katsikogiannis N, Machairiotis N, Kougioumtzi I, et al. Review of mitral valve insufficiency: Repair or replacement. <i>J Thorac Dis<\/i> 2014; 6(Suppl 1): S39\u2013S51."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Kim J, Nakatani S, Hashimura K, Komamura K, Kanzaki H, Asakura M, et al. Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy. <i>Hypertens Res<\/i> 2006; 29: 775\u2013782.","DOI":"10.1291\/hypres.29.775"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. <i>Am J Physiol Endocrinol Metab<\/i> 2001; 281: E924\u2013E930.","DOI":"10.1152\/ajpendo.2001.281.5.E924"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P)H-oxidase activation. <i>Diabetes<\/i> 2003; 52: 2795\u20132804.","DOI":"10.2337\/diabetes.52.11.2795"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Neri S, Signorelli SS, Torrisi B, Pulvirenti D, Mauceri B, Abate G, et al. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. <i>Clin Ther<\/i> 2005; 27: 1764\u20131773.","DOI":"10.1016\/j.clinthera.2005.11.006"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Mantovani A, Pernigo M, Bergamini C, Bonapace S, Lipari P, Valbusa F, et al. Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. <i>Metabolism<\/i> 2015; 64: 879\u2013887.","DOI":"10.1016\/j.metabol.2015.04.003"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Kainuma S, Taniguchi K, Daimon T, Sakaguchi T, Funatsu T, Miyagawa S, et al. Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure. <i>Circulation<\/i> 2012; 126(Suppl 1): S205\u2013S213.","DOI":"10.1161\/CIRCULATIONAHA.111.077768"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/1\/82_CJ-17-0104\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T02:47:51Z","timestamp":1602557271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/1\/82_CJ-17-0104\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0104","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}